Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Schliemann

Showing results (321-330 of 427) with videos related to

Pageof 43
Sort By:
Blood Advances|November 15, 2023
Deep learning predicts therapy-relevant genetics in acute myeloid leukemia from Pappenheim-stained bone marrow smearsJacqueline Kockwelp, Sebastian Thiele, Jannis Bartsch, et al.
Annals of Hematology|May 24, 2020
Long-term survival and polyclonal immunoglobulin reconstitution after allogeneic stem cell transplantation in multiple myelomaChristine Eisfeld, Eva Eßeling, Ramona Wullenkord, et al.
Physiological Reports|July 13, 2022
Effect of angiotensin-converting enzyme inhibition on cardiovascular adaptation to exercise trainingTórur Sjúrðarson, Jacob Bejder, Andreas Breenfeldt Andersen, et al.
British Journal of Haematology|June 4, 2024
Early blast clearance during sequential conditioning prior to allogeneic stem cell transplantation in patients with acute myeloid leukaemiaJulian Ronnacker, Marc-Andre Urbahn, Christian Reicherts, et al.
Plos One|May 13, 2016
Thoracic Malignancies and Pulmonary Nodules in Patients under Evaluation for Transcatheter Aortic Valve Implantation (TAVI): Incidence, Follow Up and Possible Impact on Treatment DecisionLars Henning Schmidt, Benedikt Vietmeier, Gerrit Kaleschke, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 26, 2026
SH2D1A/SAP Reflects Immune Activation in Melanoma and Is a Superior Predictive Biomarker of Immune Checkpoint Inhibitor Response: A Proteomic AnalysisFederico Fusco, Johannes Weigel, Marius Schliemann, et al.
Oncoimmunology|July 14, 2023
Accumulation of tissue-resident natural killer cells, innate lymphoid cells, and CD8<sup>+</sup> T cells towards the center of human lung tumorsDemi Brownlie, Andreas von Kries, Giampiero Valenzano, et al.
Leukemia Research|December 24, 2025
Relapse after allogeneic hematopoietic stem cell transplantation in patients with active acute myeloid leukemiaJulian Ronnacker, Marc-Andre Urbahn, Christian Reicherts, et al.
Plos One|October 8, 2016
A Phase I Dose Escalation Study of the Triple Angiokinase Inhibitor Nintedanib Combined with Low-Dose Cytarabine in Elderly Patients with Acute Myeloid LeukemiaChristoph Schliemann, Joachim Gerss, Stefanie Wiebe, et al.
Lung Cancer (Amsterdam, Netherlands)|January 19, 2016
Blood group antigen A type 3 expression is a favorable prognostic factor in advanced NSCLCL H Schmidt, A Kuemmel, C Schliemann, et al.
Pageof 43

Showing results (321-330 of 427) with videos related to

Sort By:
Pageof 43
Blood Advances|November 15, 2023
Deep learning predicts therapy-relevant genetics in acute myeloid leukemia from Pappenheim-stained bone marrow smearsJacqueline Kockwelp, Sebastian Thiele, Jannis Bartsch, et al.
Annals of Hematology|May 24, 2020
Long-term survival and polyclonal immunoglobulin reconstitution after allogeneic stem cell transplantation in multiple myelomaChristine Eisfeld, Eva Eßeling, Ramona Wullenkord, et al.
Physiological Reports|July 13, 2022
Effect of angiotensin-converting enzyme inhibition on cardiovascular adaptation to exercise trainingTórur Sjúrðarson, Jacob Bejder, Andreas Breenfeldt Andersen, et al.
British Journal of Haematology|June 4, 2024
Early blast clearance during sequential conditioning prior to allogeneic stem cell transplantation in patients with acute myeloid leukaemiaJulian Ronnacker, Marc-Andre Urbahn, Christian Reicherts, et al.
Plos One|May 13, 2016
Thoracic Malignancies and Pulmonary Nodules in Patients under Evaluation for Transcatheter Aortic Valve Implantation (TAVI): Incidence, Follow Up and Possible Impact on Treatment DecisionLars Henning Schmidt, Benedikt Vietmeier, Gerrit Kaleschke, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 26, 2026
SH2D1A/SAP Reflects Immune Activation in Melanoma and Is a Superior Predictive Biomarker of Immune Checkpoint Inhibitor Response: A Proteomic AnalysisFederico Fusco, Johannes Weigel, Marius Schliemann, et al.
Oncoimmunology|July 14, 2023
Accumulation of tissue-resident natural killer cells, innate lymphoid cells, and CD8<sup>+</sup> T cells towards the center of human lung tumorsDemi Brownlie, Andreas von Kries, Giampiero Valenzano, et al.
Leukemia Research|December 24, 2025
Relapse after allogeneic hematopoietic stem cell transplantation in patients with active acute myeloid leukemiaJulian Ronnacker, Marc-Andre Urbahn, Christian Reicherts, et al.
Plos One|October 8, 2016
A Phase I Dose Escalation Study of the Triple Angiokinase Inhibitor Nintedanib Combined with Low-Dose Cytarabine in Elderly Patients with Acute Myeloid LeukemiaChristoph Schliemann, Joachim Gerss, Stefanie Wiebe, et al.
Lung Cancer (Amsterdam, Netherlands)|January 19, 2016
Blood group antigen A type 3 expression is a favorable prognostic factor in advanced NSCLCL H Schmidt, A Kuemmel, C Schliemann, et al.
Pageof 43